(12. August) The two scientists study the unusually strong immune response of the survivors and then work to isolate monoclonal antibodies that neutralize the virus in their lab at Ben-Gurion University of the Negev’s Center for Emerging Diseases, Tropical Diseases and AIDS.
Yavelsky and Lobel’s monoclonal antibody-based therapeutic approach was proven as a successful potential treatment by their colleagues in the US military, and at several other laboratories.